WO2015149395A1 - 治疗慢性胃炎的中药制剂及其制备方法 - Google Patents
治疗慢性胃炎的中药制剂及其制备方法 Download PDFInfo
- Publication number
- WO2015149395A1 WO2015149395A1 PCT/CN2014/075342 CN2014075342W WO2015149395A1 WO 2015149395 A1 WO2015149395 A1 WO 2015149395A1 CN 2014075342 W CN2014075342 W CN 2014075342W WO 2015149395 A1 WO2015149395 A1 WO 2015149395A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- chinese medicine
- chronic gastritis
- licorice
- add
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 45
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 22
- 208000023652 chronic gastritis Diseases 0.000 title claims abstract description 18
- 230000000694 effects Effects 0.000 claims abstract description 37
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 20
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 20
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 19
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 19
- 229940010454 licorice Drugs 0.000 claims abstract description 19
- 244000248557 Ophiopogon japonicus Species 0.000 claims abstract description 17
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 15
- 235000008397 ginger Nutrition 0.000 claims abstract description 15
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 7
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 5
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 3
- 241001313857 Bletilla striata Species 0.000 claims abstract 4
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract 4
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 21
- 210000004369 blood Anatomy 0.000 claims description 21
- 239000008280 blood Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 244000179970 Monarda didyma Species 0.000 claims description 18
- 235000010672 Monarda didyma Nutrition 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 241000271309 Aquilaria crassna Species 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 14
- 241000756943 Codonopsis Species 0.000 claims description 12
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 241000675108 Citrus tangerina Species 0.000 claims description 9
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 8
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 6
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 5
- 240000003791 Citrus myrtifolia Species 0.000 claims description 5
- 235000000228 Citrus myrtifolia Nutrition 0.000 claims description 5
- 235000016646 Citrus taiwanica Nutrition 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 241000207929 Scutellaria Species 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 2
- 235000017803 cinnamon Nutrition 0.000 claims description 2
- 244000118681 Iresine herbstii Species 0.000 claims 3
- 244000272264 Saussurea lappa Species 0.000 claims 3
- 235000006784 Saussurea lappa Nutrition 0.000 claims 3
- 239000008213 purified water Substances 0.000 claims 3
- 241001313855 Bletilla Species 0.000 claims 2
- 241000345998 Calamus manan Species 0.000 claims 1
- 241001242909 Gallus gallus gallus Species 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 235000012950 rattan cane Nutrition 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 208000004998 Abdominal Pain Diseases 0.000 abstract description 18
- 208000002193 Pain Diseases 0.000 abstract description 17
- 230000036407 pain Effects 0.000 abstract description 17
- 206010047700 Vomiting Diseases 0.000 abstract description 15
- 230000008673 vomiting Effects 0.000 abstract description 15
- 241000287828 Gallus gallus Species 0.000 abstract description 14
- 208000024891 symptom Diseases 0.000 abstract description 13
- 201000006549 dyspepsia Diseases 0.000 abstract description 11
- 206010028813 Nausea Diseases 0.000 abstract description 10
- 230000008693 nausea Effects 0.000 abstract description 10
- 206010000059 abdominal discomfort Diseases 0.000 abstract description 5
- 230000001788 irregular Effects 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 3
- 206010000060 Abdominal distension Diseases 0.000 abstract description 2
- 208000024330 bloating Diseases 0.000 abstract description 2
- 230000000291 postprandial effect Effects 0.000 abstract description 2
- 241000271307 Aquilaria malaccensis Species 0.000 abstract 1
- 241000180579 Arca Species 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241001038562 Pseudostellaria heterophylla Species 0.000 abstract 1
- 241000501113 Sargentodoxa cuneata Species 0.000 abstract 1
- 238000002481 ethanol extraction Methods 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 description 24
- 210000000952 spleen Anatomy 0.000 description 23
- 240000002045 Guettarda speciosa Species 0.000 description 13
- 235000006533 astragalus Nutrition 0.000 description 13
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 12
- 241001061264 Astragalus Species 0.000 description 12
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 12
- 239000010931 gold Substances 0.000 description 12
- 229910052737 gold Inorganic materials 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 210000004233 talus Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 11
- 241000234314 Zingiber Species 0.000 description 10
- 208000031361 Hiccup Diseases 0.000 description 9
- 244000236658 Paeonia lactiflora Species 0.000 description 9
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 9
- 241000208340 Araliaceae Species 0.000 description 8
- 229930195210 Ophiopogon Natural products 0.000 description 8
- 206010036790 Productive cough Diseases 0.000 description 8
- 241001247821 Ziziphus Species 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000003802 sputum Anatomy 0.000 description 8
- 208000024794 sputum Diseases 0.000 description 8
- 235000012054 meals Nutrition 0.000 description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 description 6
- 241000239226 Scorpiones Species 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 235000008434 ginseng Nutrition 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 229940055726 pantothenic acid Drugs 0.000 description 6
- 235000019161 pantothenic acid Nutrition 0.000 description 6
- 239000011713 pantothenic acid Substances 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000010227 chenpi Substances 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 229940100688 oral solution Drugs 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015137 Eructation Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 208000027687 belching Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 235000020639 clam Nutrition 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 241000589151 Azotobacter Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000272199 Ciconia ciconia Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010009269 Cleft palate Diseases 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 241001593712 Daphnia sinensis Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 102100021022 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 208000028523 Hereditary Complement Deficiency disease Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000203475 Neopanax arboreus Species 0.000 description 1
- 235000019083 Osmanthus fragrans Nutrition 0.000 description 1
- 244000242564 Osmanthus fragrans Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001466532 Pelecanus erythrorhynchos Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 201000002388 complement deficiency Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000027905 limb weakness Diseases 0.000 description 1
- 231100000861 limb weakness Toxicity 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/289—Vladimiria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Definitions
- the invention relates to an agent for treating gastritis, in particular to a traditional Chinese medicine preparation for treating chronic gastritis and a preparation method thereof. Background technique
- Chronic gastritis refers to chronic inflammation of the gastric mucosa caused by different causes. The essence is that the gastric mucosal epithelium suffers repeated damage, leading to mucosal remodeling, which eventually leads to irreversible atrophy or disappearance of the intrinsic gastric gland. Chronic gastritis is often accompanied by a certain degree of atrophy (visual membrane loss) and decreased secretion of gastrin. The clinical symptoms are mainly symptoms of upper abdominal pain or discomfort, fullness, belching, nausea, and indigestion. The etiology of chronic gastritis in modern medicine has not been fully elucidated and may be related to factors such as improper diet, malnutrition, tissue congestion and hypoxia.
- the object of the present invention is to provide a traditional Chinese medicine preparation for treating gastritis on the basis of the above-mentioned deficiencies, combined with modern Chinese and Western medicine technology, in particular to provide such a traditional Chinese medicine preparation and a preparation method thereof, and the therapeutic of the present invention
- the effect is obvious, and it is non-toxic, has no side effects, and has stable effects, and the preparation process is simple and easy.
- the technical solution of the present invention is as follows:
- the preparation of the invention is from cassia twig, codonopsis pilosula, dried ginger, ginseng ginseng, licorice, woody scent, oyster shell, longan nucleus, bergamot, chicken inner gold, orange peel, agarwood, angelica, yoghurt, calcined scorpion, scutellaria, big blood Preparation of composition of vine, white peony and jujube, wherein the mass ratio of each component is Guizhi 12-20g Codonopsis 10-22g 8- 18g ginseng 10-18g licorice 8-15g woody 10-20g
- Astragalus 10-18g blood vine 8-16g white peony 8-15g jujube 10-20g
- the preferred raw material quality ratio of the present invention is cassia twig 12-18g codonopsis 10-18g dried ginger 8 - 12g ginseng 12-18g licorice 8-12g woody 10-15g oyster shell 8-12g longan core 12-16g bergamot 8-12g chicken inner gold 10-15g orange peel 10-14g agarwood 10-15g angelica 8-12g maidong 6 -10g calendered corrugated
- the present invention is also preferably a raw material cassia twig 15g codonopsis 12g dried ginger 9g
- the above preparation method for treating a chronic gastritis Chinese medicine preparation comprises the following steps:
- Codonopsis in a small pot and stir fry until the surface is slightly coke. Then crush it through the crusher and pass through the 80 mesh sieve.
- step 3 mix the powders of each component in step 1) and 2), add boiling water twice, add 10 times pure water for 1 hour, extract the filtrate for use; 6 times pure water decoction for half an hour, then combine the decoction and filter, spare;
- step 5 mixing the powders of each component in step 4), adding 4 ⁇ 6 times 70% ⁇ 80% Ethanol, heated under reflux for 3 to 5 hours, extracting and filtering to obtain a filtrate; then adding 2 to 4 times of 65% to 75% ethanol to the remaining dregs, heating and refluxing for 2 to 3 hours, extracting and filtering to obtain a filtrate
- the two obtained filtrates are combined together, concentrated under reduced pressure to remove the ethanol solvent, and dried to obtain a dry paste;
- the dry paste obtained in the above step 5) is ultra-pulverized into a powder and passed through a 200 mesh sieve, and then the powder is added to 3) the combined decoction in the step, and the mixture is shaken to obtain.
- the prepared Chinese medicine composition solution preparation can be used for oral administration, and if it can be consumed once in the morning and evening, and it is used for a long time, the effect is better.
- the theoretical basis of the invention is: cassia twig, which is a dry twig of cinnamon of the evergreen tree plant of the family Aphididae, mainly produced in Guangxi, Guangdong and Yunnan. Cut the shoots in spring and summer, dry or dry, cut into thin slices or small sections.
- the taste of Xin Wen has the function of warming the veins, dispelling the cold, and treating the qi stagnation caused by lack of yang, cold pain in the abdomen, cold and amenorrhea, etc., can also treat colds caused by cold.
- the extract of osmanthus fragrans can inhibit Escherichia coli, Bacillus subtilis and Staphylococcus aureus in vitro, with an effective concentration of 25 mg/ml or less; against Staphylococcus aureus, Shigella dysenteriae, Typhoid fever and Parahaemolyticus, Pneumococcal , Azotobacter, Proteus, Bacillus anthracis, Salmonella enteritidis, Vibrio cholerae, etc. also have inhibitory effects.
- Codonopsis pilosula has anti-stomach mucosal damage, pharmacological effects related to Buzhong Yiqi and spleen-suppressing effects to adjust gastrointestinal motility and anti-ulcer. It has enhanced immune function, enhanced hematopoietic function, anti-stress, cardiotonic, anti-shock, blood pressure regulation, anti-myocardial ischemia and platelet inhibition Aggregation and other effects. Dangshen also has the functions of puzzle, calmness, hypnosis and anti-convulsion. Dangshen has the effect of replenishing vital energy, strengthening the spleen and benefiting the lungs. For spleen and lung weakness.
- Dried ginger is a dried ginger, spicy, hot, spleen, stomach, heart, lung. It has the effect of warming and dispelling cold, returning to Yangtongmai, warming lung and drinking. It is used for spleen and stomach yang deficiency and has a cold syndrome. It can not be seen in the disease, vomiting water, loose stools, cold abdominal pain, pale tongue, white veins Subtle and so on.
- Radix Pseudostellariae also known as ginseng, is a kind of ginseng. It has a calming, sweet taste and a tonifying effect. It is often used for spleen and stomach weakness, lack of stomach yin, fatigue, indigestion, loss of appetite and so on.
- Licorice a kind of tonic Chinese herbal medicine
- the medicinal parts are roots and rhizomes.
- the roots of the medicinal properties are cylindrical, with spleen and qi, clearing away heat and detoxification, relieving cough, relieving pain, reconciling the effects of various medicines; Weary fatigue, palpitations, shortness of breath, coughing, abdominal pain, sudden pain in the limbs, swollen sore, relieve drug toxicity, potency.
- Woody is the general name for the genus Yunmuxiang and Chuanmuxiang, and is the dry root of the woody scent of Compositae.
- Woody has an antibacterial effect, can inhibit the regeneration of gastrointestinal bacteria, and can also inhibit the reproduction of liver virus replication, and play a role in reducing inflammation and protecting the liver.
- Clam shell bitter taste, cool, into the lungs, spleen, large intestine, broken gas, sputum, elimination, treatment of chest stagnation, chest, bloating, food, belching, vomiting, diarrhea Heavy, rectal prolapse, uterine prolapse and other effects.
- Longan core, miso, qi and pain, hemostasis, moisture absorption, etc. can be used for hernia pain, traumatic bleeding, phlegm, wet sores and so on. Disperse wind and evil spirits, cure dizziness, deafness, and vertigo.
- bergamot also known as the five-finger orange, bergamot, its roots, stems, leaves, flowers, and fruit can be used as medicine, bitter, spicy, sweet, warm, into the liver, spleen, stomach, lung, rational gasification, coughing It has many medicinal functions such as swelling, soothing the liver and strengthening the spleen and stomach.
- liver qi stagnation, spleen and stomach qi stagnation and phlegm and blood stasis Chicken gold, sweet and flat, into the spleen and stomach bladder, containing stomach hormones, micro pepsin, amylase, multivitamins, increase gastric secretion and gastrointestinal digestion, speed up the gastric emptying rate, etc.
- the function of digestion, solidification, and fossils, and the ability to transport the spleen and stomach, can cure the food and stagnation, and is a good medicine for stomach and digestion.
- Chenpi alias orange peel, spicy, bitter, warm; spleen, stomach, lung; qi scent, can be ascending or descending; Chenpi's bitter substance is represented by limonin and bitterness "", this kind of lemon bitter taste is mild, easy to dissolve in water, which helps digestion of food; has the effect of qi and medium, dampness and phlegm, and easy water and laxative. Indications for spleen and stomach discomfort, abdominal pain, spleen and stomach weakness, loss of appetite, vomiting hiccups, limb weakness and other symptoms, and Codonopsis, Atractylodes, yam equivalent, the effect is better.
- Angelica a perennial herb, distributed in Gansu, Yunnan, Sichuan, Qinghai, Shaanxi, Hunan, Hubei, Guizhou, etc., cultivated everywhere.
- the root of Angelica is one of the most commonly used Chinese medicines.
- Angelica has the effect of warming meridians, promoting blood circulation and relieving pain, whether it is cold and abdominal pain, or rheumatoid joint pain, or bruises and blood stasis. Angelica is also commonly used in hemorrhoids. Because Angelica activating blood circulation and dissipating blood stasis, it can reduce swelling and relieve pain and discharge pus muscle.
- the famous Fangfang Xiagging Live Drink for treating sores is equivalent to Angelica and Red Oak, Honeysuckle and Gunsan.
- Ophiopogon japonicus is a perennial evergreen grass plant of the genus Liliaceae. The fibrous roots are thicker and thicker.
- the top or middle part of the root is often expanded into a spindle-shaped succulent piece, which is used as a root.
- Maimendong has the effect of raising white blood cells, prolonging the time of antibody, improving immune function and nucleic acid synthesis rate, and promoting the production of immune substances such as antibodies, complement, interferon and lysozyme. . Therefore, Ophiopogon has the effect of strengthening the righteousness and strengthening the anti-evil effect, thereby reducing the incidence of disease. It is used for lung and stomach yin deficiency, less thirst, dry cough and hemoptysis, heart yin deficiency, heart irritability and heat syndrome in the late stage of fever.
- Calcined scorpion sweet, flat, liver, lung, stomach. It has the effects of eliminating phlegm and dissipating phlegm, softening and firming, and acid-relieving pain. Mainly used for pantothenic acid, stubborn accumulation, sticky and difficult to embolize. Astragalus, Astragalus, alias Camellia root, earth tea root. For the plant of the Labiatae, the root is used as a medicine. It has heat and dampness, cool blood and fetus, detoxification effect.
- the clinical application of Astragalus is better than berberine and does not produce drug resistance. Big blood vine, bitter, flat.
- Jujube, sweet and warm, spleen and stomach rich in protein, fat, sugar, carotene, B vitamins, vitamin C, vitamin P and calcium, phosphorus, iron and cyclic adenosine monophosphate and other nutrients.
- the content of vitamin C is among the best in the fruit, and it has the reputation of vitamin king. It has the effect of replenishing vital energy, strengthening the spleen and stomach, nourishing blood and calming the nerves, and alleviating the medicinal properties. It is used for spleen deficiency, fatigue, and impotence.
- the oral solution of the preparation of the present invention is taken half an hour after a meal, 3 times a day, 200 ml each time, 2 months for a course of treatment, and 3 courses for observation of curative effect.
- the oral solution of the preparation of the present invention is taken half an hour after a meal, 3 times a day, 200 ml each time, 2 months for a course of treatment, and 3 courses for observation of curative effect.
- the oral solution of the preparation of the present invention is taken half an hour after a meal, 3 times a day, 200 ml each time, 2 months for a course of treatment, and 3 courses for observation of curative effect.
- the preparation of the invention is from cassia twig, codonopsis pilosula, dried ginger, ginseng ginseng, licorice, woody scent, oyster shell, longan nucleus, bergamot, chicken inner gold, orange peel, agarwood, angelica, yoghurt, calcined scorpion, scutellaria, big blood
- a preparation preparation of vine, white peony and jujube, wherein the mass ratio of each component is Guizhi 12g Codonopsis 10g 10g
- Codonopsis in a small pot and stir fry until the surface is slightly coke. Then crush it through the crusher and pass through the 80 mesh sieve.
- step 5 mixing the powders of each component in step 4), adding 4 to 6 times 70% ⁇ 80% ethanol, heating and refluxing for 3 to 5 hours, extracting and filtering to obtain a filtrate; and then remaining the dregs Adding 2 to 4 times of 65% to 75% ethanol again, heating and refluxing for 2 to 3 hours, extracting and filtering to obtain a filtrate; combining the filtrates obtained twice, removing the ethanol solvent under reduced pressure, and drying to obtain a dry paste. ;
- the dry paste obtained in the above step 5) is ultra-pulverized into a powder and passed through a 200 mesh sieve, and then the powder is added to the combined decoction in the step 3), and mixed and shaken to obtain.
- the prepared Chinese medicine composition solution preparation can be used for oral administration, and if it can be consumed once in the morning and evening and long-term drinking, the effect is better.
- Example 2
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- the preferred raw material quality of the present invention is (g):
- the preferred raw material quality of the present invention is (g): Guizhi 18g Codonopsis 15g Dried ginger 12g Radix Pseudostellariae 16g Licorice 12g Woody 15g Clam shell 13g Longan core 15g Bergamot 12g Chicken inner gold 16g Tangerine 14g Agarwood 16g Angelica 10g Ophiopogon 12g 'Rolled cork 15g Astragalus 16g Big blood vine 13g White peony 12g Jujube 18g.
- the preparation method is as in Example 1.
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗慢性胃炎的中药制剂及其制备方法。所述制剂是由桂枝、党参、干姜、太子参、甘草、木香、枳壳、龙眼核、佛手、鸡内金、陈皮、沉香、当归、麦冬、煅瓦楞子、黄芩、大血藤、白及和大枣经过粉碎、煎煮、乙醇提取及混合等工序制备成的液体制剂。该制剂治疗慢性胃炎效果明显,对于饭后饱胀、泛酸、无规律性腹痛、上腹部不适、疼痛、消化不良、呕吐、呃逆、恶心等症状有明显效果,且制备方法简单,效果稳定,副作用小。
Description
治疗慢性胃炎的中药制剂及其制备方法
技术领域
本发明涉及一种治疗胃炎的药剂,具体涉及一种治疗慢性胃炎的 中药制剂及其制备方法。 背景技术
慢性胃炎, 是指由不同的病因引起的胃粘膜的慢性炎症, 其实质 是胃粘膜上皮遭受反复损害后, 导致粘膜发生改建, 最终导致不可逆 的固有胃腺体的萎缩,甚至消失。慢性胃炎常伴有一定程度的萎缩 (粘 膜丧失功能) 和胃泌素分泌减少,临床症状主要表现为上腹疼痛或不 适、 饱胀、 嗳气、 恶心、 消化不良等症状。 现代医学对慢性胃炎的病 因尚未完全阐明, 认为可能与饮食不当、 营养不良、 组织淤血和缺氧 等因素有关。目前,患者通常服用西药来治疗,但是西药治标不治本, 只能暂时缓解症状, 并不能根除病根, 而且在治疗胃炎的同时, 还往 往会伤及肝肾等器官, 疗效不稳定, 容易复发。 发明内容
本发明的目的即在于针对上述不足, 在祖传秘方的基础上, 结合 现代中西医技术, 提供一种胃炎治疗的中药制剂, 具体的说是提供这 种中药制剂及其制备方法, 本发明胃炎治疗效果明显, 而且无毒, 无 副作用, 效果稳定, 制取工艺简便易行。
本发明的技术方案如下所述:
本发明制剂是由桂枝、党参、干姜、太子参、甘草、木香、枳壳、 龙眼核、佛手、鸡内金、 陈皮、沉香、 当归、麦冬、煅瓦楞子、黄芩、 大血藤、白芨和大枣制备成的组合物制剂,其中各组分的质量配比为 桂枝 12-20g 党参 10-22g 8- 18g 太子参 10-18g 甘草 8-15g 木香 10- 20g
8— 16g 龙眼核 12-20g 佛手 8- 16g 鸡内金 10-18g 陈皮 10-18g 沉香 10- 18g 当归 8-15g 麦冬 6-15g 煅瓦楞子
8-15g
黄芩 10-18g :血藤 8-16g 白芨 8-15g 大枣 10-20g( 为了获得更好的效果, 本发明可优选的原料质量配比为 桂枝 12-18g 党参 10-18g 干姜 8-12g 太子参 12-18g 甘草 8-12g 木香 10-15g 枳壳 8-12g 龙眼核 12-16g 佛手 8-12g 鸡内金 10-15g 陈皮 10-14g 沉香 10-15g 当归 8-12g 麦冬 6-10g 煅瓦楞子
8-12g
黄芩 10-15g :血藤 8-12g 白芨 8-12g 大枣 12-18g <
当然, 为了获得进一歩好的效果, 本发明还可优选的原料质 桂枝 15g 党参 12g 干姜 9g
太子参 15g 甘草 10g 木香 12g
枳壳 12g 龙眼核 10g 佛手 8g
鸡内金 12g 陈皮 14g 沉香 12g
当归 8g 麦冬 8g 煅瓦楞子 12g 黄芩 10g 大血藤 8g 白芨 10g
大 15g0
上述治疗慢性胃炎中药制剂的制备方法, 包括如下歩骤:
1 )、将党参放入小锅进行小炒至表面微焦, 然后经粉碎机粉碎并 过 80目筛, 备用;
2 )、将桂枝、干姜、太子参、甘草、枳壳、龙眼核、佛手、大枣、 黄芩、 大血藤按比例配好, 经过粉碎机粉碎成粉末并过 90 目筛, 自 然晾干, 备用;
3 )、 将歩骤 1 ) 和 2 ) 中的各组分粉末混合在一起, 加入纯净水 煎煮两次, 第一次加入 10倍纯净水煎煮 1小时, 提取滤液备用; 第 二次加入 6倍纯净水煎煮半小时, 然后合并煎液并过滤, 备用;
4 )、 将剩下的木香、 鸡内金、 陈皮、 沉香、 当归、 麦冬、 煅瓦楞 子、 白芨按比例配好, 经过粉碎机粉碎成粉末并过 80 目筛, 自然晾 干, 备用;
5 )、 将歩骤 4) 中各组分粉末混合在一起, 加入 4〜6倍70%〜80%
的乙醇, 加热回流 3〜5个小时, 提取过滤获得滤液; 然后在剩下的药 渣中再次加入 2〜4倍65%〜75%的乙醇, 加热回流 2〜3个小时, 提取过 滤获得滤液;将两次获得的滤液合并在一起,减压浓缩除去乙醇溶剂, 干燥, 获得干膏;
6 )、 将上述歩骤 5 ) 中获得的干膏进行超微粉碎成粉末并过 200 目筛, 然后将粉末加入 3 ) 歩骤中的合并煎液, 混合摇匀即可制得。
制取的上述中药组合物溶液制剂可以用于口服,如果能够早中晚 各适量饮用一次并长期饮用, 效果更好。 本发明的理论依据在于: 桂枝, 为樟科常绿乔木植物肉桂的干燥嫩枝, 主产于广西、 广东 及云南等地。 春、 夏季剪下嫩枝, 晒干或阴干, 切成薄片或小段用。 行味辛温, 有温经通脉, 散寒解表的作用, 治疗阳气不足引起的气滞 血凝, 脘腹冷痛, 血寒经闭等症, 也可治疗因受冷引起的风寒感冒, 流涕咳嗽等病有很好的作用。桂枝醇提物在体外能抑制大肠杆菌、枯 草杆菌及金黄色葡萄球菌, 有效浓度为 25毫克 /毫升或以下; 对白色 葡萄球菌、 志贺氏痢疾杆菌、 伤寒和副伤寒甲杆菌、 肺炎球菌、 产气 杆菌、 变形杆菌、 炭疽杆菌、 肠炎沙门氏菌、 霍乱弧菌等亦有抑制作 用。 党参, 有抗胃黏膜损伤作用, 补中益气、 健脾功效相关的药理作 用为调整胃肠运动功能、 抗溃疡。 具有增强机体免疫功能、 增强造血 功能、 抗应激、 强心、 抗休克、 调节血压、 抗心肌缺血和抑制血小板
聚集等作用。 党参还具有益智、 镇静、 催眠、 抗惊厥等作用。 党参具 有补中益气, 健脾益肺的功效。 用于脾肺虚弱等。 干姜, 是生姜的干品, 味辛, 性热, 归脾、 胃、 心、 肺经。 具有 温中散寒,回阳通脉,温肺化饮的功效,用于脾胃阳虚而出现里寒证, 症见积食不消, 呕吐清水, 大便稀, 腹冷痛, 舌淡苔白, 脉沉细等。 太子参, 太子参又称为童参, 是人参的一种, 药性平和、 味甘, 有补气生津的作用, 常用于脾胃虚弱, 胃阴不足, 倦怠乏力、 消化不 良, 食欲不振等。 甘草, 是一种补益中草药, 药用部位是根及根茎, 药材性状根呈 圆柱形, 具有补脾益气, 清热解毒, 祛痰止咳, 缓急止痛, 调和诸药 的作用; 用于脾胃虚弱, 倦怠乏力, 心悸气短, 咳嗽痰多, 脘腹、 四 肢挛急疼痛, 痈肿疮毒, 缓解药物毒性、 烈性。 木香, 是菊科植物云木香和川木香的通称,是菊科植物木香的干燥 根。 木香有抗菌作用, 能够抑制胃肠细菌的再生, 还能抑制肝脏病毒的 复制的繁殖, 起到消炎护肝的作用。 枳壳, 性味苦辛、凉, 入肺、脾、大肠经, 有破气, 行痰, 消积、 治胸膈痰滞、 胸痞、 胁胀、 食、 噫气、 呕逆、 下痢后重, 脱肛, 子宫 脱垂等功效。
龙眼核, 味涩、 有理气止痛、 止血、 收湿等功效, 可用于疝气疼 痛、外伤出血、疥癣、湿疮等。散风邪风, 治心虚头暈、耳聋、眼花。 温肾利尿, 止血, 定痛, 理气, 化湿; 主治氕脏邪气, 治厌食、 食欲 不振, 驱肠叶寄生虫及血吸虫。 长期食用, 强体魄, 延年益寿, 安神 健脑长智慧, 开胃健脾, 补体虚。 佛手, 又名五指橘, 佛手柑, 其根、 茎、 叶、 花、 果均可入药, 味苦、 辛、 甘、 温, 入肝、 脾、 胃、 肺经, 有理气化痰, 止咳消胀、 舒肝健脾和胃等多种药用功能, 有疏肝解郁、 燥湿化痰、 理气和中的 功效, 常用于肝郁气滞、 脾胃气滞和痰湿壅肺等症。 鸡内金, 味甘性平, 入脾胃膀胱经, 含胃激素、 微量胃蛋白酶, 淀粉酶、 多种维生素, 有增加胃液分泌量和胃肠消化能力, 加快胃的 排空速率等作用, 有健胃消食, 固精止遗、 化石通淋之功能, 且能健 运脾胃, 可治饮食积滞, 为健胃消食之良药。 陈皮, 别名橘皮, 味辛、苦, 性温; 归脾、 胃、肺经; 气香宣散, 可升可降; 陈皮的苦味物质是以柠檬苷和苦味素为代表的 "类柠檬苦 素" , 这种类柠檬苦素味平和, 易溶解于水, 有助于食物的消化; 具有 理气和中, 燥湿化痰, 利水通便的功效。 主治脾胃不和、 脘腹胀痛、 脾胃虚弱、 食欲不振、 呕吐哕逆、 肢倦无力等症, 和党参、 白术、 山 药等同用, 效果较好。
沉香, 性味辛、 苦, 微温, 归脾、 胃、 肾经, 具有行气止痛, 温 中止呕, 暖肾纳气等功效, 主治呕吐呃逆, 脘腹胀痛, 腰膝虚冷, 大 肠虚秘, 胸腹胀闷疼痛, 胃寒呕吐呃逆, 肾虚气逆喘急等。 当归, 多年生草本植物,分布于甘肃、云南、 四川、青海、陕西、 湖南、 湖北、 贵州等地, 各地均有栽培。 当归的根可入药, 是最常用 的中药之一。 当归有温通经脉、 活血止痛的功效, 无论虚寒腹痛, 或 风湿关节疼痛, 或跌打损伤瘀血阻滞疼痛, 都可使用当归。 当归也常 用于痈疽疮疡。 因为当归活血化瘀, 能起到消肿止痛、 排脓生肌的功 效。 治疗疮疡的名方仙方活命饮, 就以当归与赤芍、 金银花、 炮山甲 等同用。 麦冬, 为百合科沿阶草属多年生常绿草本植物, 须根较粗壮, 根 的顶端或中部常膨大成为纺锤状肉质小块, 以块根入药。 性微寒,味 甘微苦,药理实验证明,麦门冬有升高白细胞,延长抗体存在时间的作用, 提高免疫功能和核酸合成率,促进抗体、 补体、 干扰素、 溶菌酶等免疫 物质产生。因此麦冬有增强正气、加强抗邪作用,从而减少疾病的产生。 用于肺胃阴虚之津少口渴、干咳咯血、心阴不足之心悸易惊及热病后期 热伤津液等症。 煅瓦楞子, 味甘、 性平, 归肝、 肺、 胃经。 具有消痰化瘀, 软坚 散结, 制酸止痛的功效。 主要用于胃痛泛酸, 顽痰积结, 粘稠难咯等 症。
黄芩, 黄芩别名山茶根、 土金茶根。 为唇形科植物, 以根入药。 有 清热燥湿, 凉血安胎, 解毒功效。 主治温热病、 上呼吸道感染、 肺热咳 嗽、 湿热黄胆、 肺炎、 痢疾、 咳血、 目赤、 胎动不安、 高血压、 痈肿疖 疮等症。 黄芩的临床应用抗菌比黄连还好, 而且不产生抗药性。 大血藤, 味苦, 平。 归大肠、肝经。功能主治: 清热解毒, 活血, 祛风。 用于肠痈腹痛, 经闭痛经, 风湿痹痛, 跌扑肿痛。 具有败毒消 痈, 活血通络, 祛风杀虫的作用。 治急、 慢性阑尾炎, 风湿痹痛, 赤 痢, 血淋, 月经不调, 疳积, 虫痛, 跌扑损伤等症。 白芨, 性寒、 味苦、 甘、 涩, 无毒; 归肺、 胃、 肝经。 具有收敛止 血, 消肿生肌的功能。 主治肺痨略血, 吐血, 衄血, 便血, 外伤出血, 痈疮肿毒, 瘰疬, 痔漏, 烧烫伤, 手足皲裂, 肛裂等病症。 与本发明其 他中药配伍, 治疗胃炎效果明显。 大枣, 味甘性温, 归脾胃经, 富含蛋白质、 脂肪、 糖类、 胡萝卜 素、 B族维生素、 维生素 C、 维生素 P以及钙、 磷、 铁和环磷酸腺苷等 营养成分。其中维生素 C的含量在果品中名列前茅,有维生素王之美称。 具有补中益气,健脾益胃,养血安神,缓和药性的功效。用于脾虚食少, 乏力便溏, 妇人脏躁。 从我国传统中医角度讲, 慢性胃炎的病因病机, 有饮食不节, 戕 伤中州,或外邪内侵,损及脾胃,或忧患郁怒,肝失疏泄,横逆犯胃, 以及禀赋不足, 脾胃虚弱等情形, 其病表在 "胃 " , 但与 "脾" 、
"肝" 、 "肾"却关系密切, 病机特点是虚中夹实, 因此通过本发明 上述中药配伍以及制备方法获得的组合物,采用辩证的方法有效的达 到调理胃与五脏六腑的功效, 无毒副作用, 效果稳定, 与西药相比达 到事半功倍的疗效。 临床实验 1:
1 )、观察时间:在本发明技术方案未曾披露的情况下,选择 2013 年 3月到 2013年 8月的 6个月时间。
2 )、 观察对象: 在广东省深圳市中医院消化科选择 10例慢性胃 炎病例: 男 6例, 女 4例; 年龄: 35— 55岁 5例, 55— 75岁 5例; 职业: 普通上班族 5例, 退休人员 5例。 病症: 饭后饱胀, 泛酸, 无 规律性腹痛等症状。
3 )、 使用方法: 将本发明制剂口服液在餐后半小时服用, 每日 3 次, 每次 200ml, 2个月为 1疗程, 3个疗程作为疗效观察。
4 )、 观察效果:
在连续服用 3个疗程后, 饭后饱胀, 泛酸, 无规律性腹痛等症状 基本不再出现的 5例, 饭后稍微有饱胀感, 轻微泛酸, 无规律性轻微 腹痛等症状基本不再出现的 4例, 饭后饱胀, 泛酸, 无规律性腹痛改 善不明显的 1例, 总有效率 90%。
临床实验 2:
1 )、观察时间: 在本发明技术方案未曾披露的情况下, 选择 2013 年 5月到 2013年 10月的 6个月时间。
2 )、 观察对象: 在广东省深圳市福田区中医院消化科选择 20例 病例: 男 12例, 女 8例; 年龄: 30— 55岁 10例, 55— 75岁 10例; 职业: 曾担任领导岗位公务员 10例, 普通教师 10例。 病症: 上腹部 不适, 疼痛, 消化不良, 呕吐, 呃逆恶心等。
3 )、 使用方法: 将本发明制剂口服液在餐后半小时服用, 每日 3 次, 每次 200ml, 2个月为 1疗程, 3个疗程作为疗效观察。
4 )、 观察效果:
在连续服用 3个疗程后, 病人原先的腹部疼痛, 消化不良已经消 失, 呕吐, 呃逆和恶心等基本不再出现的 12例, 轻微腹部疼痛和消 化不良, 偶尔轻微呕吐, 呃逆和恶心的 4例, 腹部疼痛, 消化不良已 经消失, 呕吐, 呃逆和恶心改善不明显的 4例, 总有效率 80%。
临床实验 3:
1 )、观察时间: 在本发明技术方案未曾披露的情况下, 选择 2013 年 6月到 2013年 11月的 6个月时间。
2 )、 观察对象: 在广东省深圳市松岗人民医院消化科选择 30例 病例: 男 12例, 女 18例; 年龄: 30— 55岁 16例, 55— 75岁 14例; 职业: 普通民营企业主 14例, 普通教师 16例。 病症: 饭后饱胀, 泛 酸, 无规律性腹痛, 上腹部不适, 疼痛, 消化不良, 呕吐, 呃逆恶心
3 )、 使用方法: 将本发明制剂口服液在餐后半小时服用, 每日 3 次, 每次 200ml, 2个月为 1疗程, 3个疗程作为疗效观察。
4 )、 观察效果:
在连续服用 3个疗程后, 病人原先的腹部疼痛, 消化不良已经消 失, 呕吐, 呃逆和恶心等基本不再出现的 20例, 轻微腹部疼痛和消 化不良, 偶尔轻微呕吐, 呃逆和恶心的 5例, 腹部疼痛, 消化不良, 呕吐, 呃逆和恶心改善不明显的 5例, 总有效率 83%。 结合以上临床数据及本发明的理论依据,可见本发明有益效果在 于,本发明制成的制剂,对于治疗慢性胃炎具有良好效果,而且无毒, 无副作用, 效果稳定, 制取工艺简便易行。 具体实 式
下面结合实施例对本发明详细加以说明:
实施例 1:
本发明制剂是由桂枝、党参、干姜、太子参、甘草、木香、枳壳、 龙眼核、佛手、鸡内金、 陈皮、沉香、 当归、麦冬、煅瓦楞子、黄芩、 大血藤、白芨和大枣制备成的组合物制剂,其中各组分的质量配比为 桂枝 12g 党参 10g
10g
太子参 12g 甘草 12g 木香 15g
枳壳 10g 龙眼核 12g 佛手 8g
鸡内金 15g 陈皮 15g 沉香 13g
当归 12g 麦冬 8g 煅瓦楞子 10g 黄芩 12g 大血藤 13g 白芨 10g
大 16g0
上述治疗慢性胃炎中药制剂的制备方法, 包括如下歩骤:
1 )、将党参放入小锅进行小炒至表面微焦, 然后经粉碎机粉碎并 过 80目筛, 备用;
2 )、将桂枝、干姜、太子参、甘草、枳壳、龙眼核、佛手、大枣、 黄芩、 大血藤按比例配好, 经过粉碎机粉碎成粉末并过 90 目筛, 自 然晾干, 备用;
3 )、 将歩骤 1 ) 和 2 ) 中的各组分粉末混合在一起, 加入纯净水 煎煮两次, 第一次加入 8倍纯净水小火煎煮 1小时, 第二次加入 4倍 纯净水小火煎煮半小时, 然后合并煎液并过滤, 备用;
4 )、 将剩下的木香、 鸡内金、 陈皮、 沉香、 当归、 麦冬、 煅瓦楞 子、 白芨按比例配好, 经过粉碎机粉碎成粉末并过 80 目筛, 自然晾 干, 备用;
5 )、 将歩骤 4) 中各组分粉末混合在一起, 加入 4〜6倍70%〜80% 的乙醇, 加热回流 3〜5个小时, 提取过滤获得滤液; 然后在剩下的药 渣中再次加入 2〜4倍65%〜75%的乙醇, 加热回流 2〜3个小时, 提取过 滤获得滤液;将两次获得的滤液合并在一起,减压浓缩除去乙醇溶剂, 干燥, 获得干膏;
6 )、 将上述歩骤 5 ) 中获得的干膏进行超微粉碎成粉末并过 200 目筛, 然后将粉末加入歩骤 3 ) 中的合并煎液, 混合摇匀即可制得。
制取的上述中药组合物溶液制剂可以用于口服,如果能够早中晚 各饮用一次并长期饮用, 效果更好。
实施例 2:
本发明还可优选的原料质量为 (克):
桂枝 12g 党参 10g 干姜 10g 太子参 12g 甘草 12g 木香 15g 枳壳 10g 龙眼核 12g 佛手 8g 鸡内金 15g 陈皮 10g 沉香 13g 当归 12g 麦冬 8g 煅瓦楞子 10g 黄芩 12g 大血藤 13g
10g 大 16g。
制备方法如实施例 1。
实施例 3:
本发明还可优选的原料质量为 (克):
桂枝 15g 党参 12g 干姜 9g 太子参 15g 甘草 10g 木香 12g 枳壳 12g 龙眼核 10g 佛手 8g 鸡内金 12g 陈皮 14g 沉香 12g 当归 8g 麦冬 8g 煅瓦楞子 12g 黄芩 10g 大血藤 8g
10g 大 15g0
制备方法如实施例 1 (
实施例 :
本发明还可优选的原料质量为 (克):
桂枝 18g 党参 15g 干姜 12g 太子参 16g 甘草 12g 木香 15g 枳壳 13g 龙眼核 15g 佛手 12g 鸡内金 16g 陈皮 14g 沉香 16g 当归 10g 麦冬 12g '煅瓦楞子 15g 黄芩 16g 大血藤 13g 白芨 12g 大枣 18g。
制备方法如实施例 1。
实施例 5:
本发明还可优选的原料质量为 (克):
桂枝 16g 党参 18g
太子参 14g 甘草 15g
枳壳 15g 龙眼核 18g
制备方法如实施例 1。
实施例 6:
本发明还可优选的原料
桂枝 15g 党 15g 太子参 16g 甘 20g
枳壳 12g 龙眼核 20g 16g 鸡内金 16g 陈皮 18g log 当归 15g 麦冬 15g 煅瓦楞子 12g 黄芩 16g 大血藤 16g 白芨 13g 大枣 20g。
上述实施例仅是本发明众多实施方式的几种,如将各配方按技术方案 中的比例加大或减小药量,制得的这种治疗慢性胃炎制剂疗效并不受 影响, 也将落在本发明的权利保护范围之内 沉佛
香手
Claims
1、 一种治疗慢性胃炎的中药制剂, 其特征在于, 本发明制剂是 由桂枝、 党参、 干姜、 太子参、 甘草、 木香、 枳壳、 龙眼核、 佛手、 鸡内金、 陈皮、 沉香、 当归、 麦冬、 煅瓦楞子、 黄芩、 大血藤、 白芨 和大枣制备成的组合物制剂, 其中各组分的质量配比为:
桂枝 12-20g 党参 10-22g 8-18g 太子参 10-18g 甘草 8-15g 木香 10- 20g 枳壳 8-16g 龙眼核 12-20g 佛手 8- 16g 鸡内金 10-18g 陈皮 10-18g 沉香 10-18g
8-15g 麦冬 6-15g 煅瓦楞子
8-15g
10— 18g :血藤 8-16g 白芨 8- 15g 大枣 10-20g。
2、 根据权利要求 1所述的治疗慢性胃炎的中药制剂, 其特征还 在于, 其中各组分的质量配比为:
桂枝 12-18g 10-18g 8-12g 太子参 12-18g 甘草 8-12g 木香 10-15g
8-12g 龙眼核 12-16g 佛手 8-12g 鸡内金 10-15g 陈皮 10-14g 沉香 10-15g 当归 8-12g 麦冬 6-10g 煅瓦楞子
8-12g
黄芩 10-15g :血藤 8-12g 白芨 8-12g
大枣 12-18g。
3、 根据权利要求 1或 2所述的治疗慢性胃炎的中药制剂, 其特 征还在于, 其中各组分的质量配比为:
桂枝 15g 党参 12g 干姜 9g
太子参 15g 甘草 10g 木香 12g
枳壳 12g 龙眼核 10g 佛手 8g
鸡内金 12g 陈皮 14g 沉香 12g
当归 8g 麦冬 8g 煅瓦楞子 12g 黄芩 10g 大血藤 8g 白芨 10g
大 15g0
4、 一种治疗慢性胃炎的中药制剂的制备方法, 其特征在于, 其 包括如下歩骤:
1 )、将党参放入小锅进行小炒至表面微焦, 然后经粉碎机粉碎并 过 80目筛, 备用;
2 )、将桂枝、干姜、太子参、甘草、枳壳、龙眼核、佛手、大枣、 黄芩、 大血藤按比例配好, 经过粉碎机粉碎成粉末并过 90 目筛, 自 然晾干, 备用;
3 )、 将歩骤 1 ) 和 2 ) 中的各组分粉末混合在一起, 加入纯净水 煎煮两次,第一次加入 10倍纯净水小火煎煮 1小时,提取滤液备用, 第二次加入 6倍纯净水小火煎煮半小时,然后合并煎液并过滤,备用;
4 )、 将剩下的木香、 鸡内金、 陈皮、 沉香、 当归、 麦冬、 煅瓦楞 子、 白芨按比例配好, 经过粉碎机粉碎成粉末并过 80 目筛, 自然晾
干, 备用;
5 )、 将歩骤 4 ) 中各组分粉末混合在一起, 加入 4〜6倍70%〜80% 的乙醇, 加热回流 3〜5个小时, 提取过滤获得滤液; 然后在剩下的药 渣中再次加入 2〜4倍65%〜75%的乙醇, 加热回流 2〜3个小时, 提取过 滤获得滤液;将两次获得的滤液合并在一起,减压浓缩除去乙醇溶剂, 干燥, 获得干膏;
6 )、 将上述歩骤 5 ) 中获得的干膏进行超微粉碎成粉末并过 200 目筛, 然后将粉末加入歩骤 3 ) 中的合并煎液, 混合摇匀即可制得。 制取的上述中药组合物溶液制剂可以用于口服,如果能够早中晚各适 量饮用一次并长期饮用, 效果更好。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410123822.9 | 2014-03-31 | ||
CN201410123822.9A CN103893726A (zh) | 2014-03-31 | 2014-03-31 | 治疗慢性胃炎的中药制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015149395A1 true WO2015149395A1 (zh) | 2015-10-08 |
Family
ID=50985510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/075342 WO2015149395A1 (zh) | 2014-03-31 | 2014-04-15 | 治疗慢性胃炎的中药制剂及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103893726A (zh) |
WO (1) | WO2015149395A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109481662A (zh) * | 2018-12-28 | 2019-03-19 | 商洛市中医医院 | 黄精二冬养胃汤 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103877548A (zh) * | 2014-03-31 | 2014-06-25 | 袁志贤 | 一种治疗慢性肠炎的中药制剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101138616A (zh) * | 2007-09-08 | 2008-03-12 | 门连社 | 一种治疗胃病的方剂 |
CN102727755A (zh) * | 2012-06-27 | 2012-10-17 | 彭德钊 | 治疗胃溃疡病的中药组合物 |
CN102727819A (zh) * | 2012-07-05 | 2012-10-17 | 陈光明 | 治疗消化系统疾病的保康灵多元益生素口服液及制备方法 |
CN102824587A (zh) * | 2011-07-07 | 2012-12-19 | 随洪涛 | 一种治疗胃病的中药配方 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552855B (zh) * | 2012-02-15 | 2013-10-30 | 张秀兰 | 一种治疗胃胀的药物及其制备方法 |
-
2014
- 2014-03-31 CN CN201410123822.9A patent/CN103893726A/zh active Pending
- 2014-04-15 WO PCT/CN2014/075342 patent/WO2015149395A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101138616A (zh) * | 2007-09-08 | 2008-03-12 | 门连社 | 一种治疗胃病的方剂 |
CN102824587A (zh) * | 2011-07-07 | 2012-12-19 | 随洪涛 | 一种治疗胃病的中药配方 |
CN102727755A (zh) * | 2012-06-27 | 2012-10-17 | 彭德钊 | 治疗胃溃疡病的中药组合物 |
CN102727819A (zh) * | 2012-07-05 | 2012-10-17 | 陈光明 | 治疗消化系统疾病的保康灵多元益生素口服液及制备方法 |
Non-Patent Citations (1)
Title |
---|
YANG, JINGHAI;: "Treatment of Chronic Gastritis by Traditional Chinese Medicine", GUANGMING JOURNAL OF CHINESE MEDICINE, 20 April 1998 (1998-04-20), pages 11 - 17 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109481662A (zh) * | 2018-12-28 | 2019-03-19 | 商洛市中医医院 | 黄精二冬养胃汤 |
CN109481662B (zh) * | 2018-12-28 | 2021-10-19 | 商洛市中医医院 | 黄精二冬养胃汤 |
Also Published As
Publication number | Publication date |
---|---|
CN103893726A (zh) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169903A (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
CN103977078B (zh) | 一种治疗人痢疾病的中药制剂及其生产方法 | |
CN103861014B (zh) | 一种治疗慢性胃炎的中药口服液 | |
CN103349693B (zh) | 一种治疗过敏性鼻炎的外用中药组合物 | |
CN104001045A (zh) | 一种用于治疗犬肺炎的药物及其制备方法 | |
WO2015149395A1 (zh) | 治疗慢性胃炎的中药制剂及其制备方法 | |
WO2015149393A1 (zh) | 一种治疗慢性胃炎的中药及其制备方法 | |
WO2015149391A1 (zh) | 一种治疗慢性肠炎的中药制剂及其制备方法 | |
CN104984237A (zh) | 一种中药组合物及其制备方法 | |
CN104548021A (zh) | 一种辅助肿瘤患者放化疗后康复用中药组合物 | |
CN104173973A (zh) | 一种治疗痢疾的口服液及其制备方法 | |
CN104740405B (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 | |
CN102772645B (zh) | 一种治疗感冒的中药制剂及其制备方法 | |
CN108066731B (zh) | 一种治疗Barrett食管的中草药组合物及其制备方法和应用 | |
CN104721670A (zh) | 一种治疗咽喉炎的中药组合物及制备方法 | |
CN104398902A (zh) | 虚寒型慢性支气管炎清热宣肺制剂及制法 | |
CN103977073A (zh) | 一种预防及治疗感冒的中药含片及其生产方法 | |
CN104189514A (zh) | 淋巴结核软坚祛痰制剂及制法 | |
CN104707003B (zh) | 治疗高血压、高血脂的中药胶囊 | |
CN103585434A (zh) | 一种治疗贫血的中药组合物 | |
CN108310292A (zh) | 用于治疗慢性支气管炎的中草药方剂 | |
CN107823538A (zh) | 一种治疗急性胃炎的中药制剂及其制备方法 | |
CN106166263A (zh) | 根治疟疾的中药浓缩丸 | |
CN105079440A (zh) | 一种防治哮喘的润肺化痰制剂及制法 | |
CN104840901A (zh) | 治疗百日咳的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14887863 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 06/04/2017) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14887863 Country of ref document: EP Kind code of ref document: A1 |